Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PharmX Technologies ( (AU:PHX) ) just unveiled an announcement.
PharmX Technologies reported a strong third quarter to 31 March 2026, highlighting rapid growth in its Marketplace platform and deeper integration into the pharmacy ecosystem. The company achieved record monthly Marketplace gross transaction value above $1.3 million in March, with 57% month-on-month growth, followed by a further 42% uplift in April, and now expects to surpass a $100 million annualised run rate within 12 months.
The period also saw Sigma Healthcare take an initial 10% stake and renew its wholesale EDI agreement for five years, cementing PharmX as the preferred electronic data interchange and growth partner for Sigma and Chemist Warehouse across Australia and New Zealand. Supplier additions, including about 5,000 new ParagonCare SKUs, and expanded customer success resources underscore PharmX’s shift into execution mode, reinforcing its role as essential operating infrastructure for pharmacies and supporting its long-term value proposition for customers, partners and shareholders.
More about PharmX Technologies
PharmX Technologies, listed on the ASX, operates a leading pharmacy ordering network across Australia and New Zealand, connecting more than 7,000 pharmacies with wholesalers and suppliers. Its digital infrastructure supports around $23 billion in gross transaction value, positioning the company as a core technology provider to the broader pharmacy supply chain and major networks such as Sigma Healthcare and Chemist Warehouse.
Average Trading Volume: 704,074
Technical Sentiment Signal: Buy
Current Market Cap: A$58.03M
See more data about PHX stock on TipRanks’ Stock Analysis page.